# Nuclide record b-site-readiness-referral (bottleneck). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/bottlenecks/b-site-readiness-referral/>
  a schema:Thing ;
  nuclide:kind "bottleneck" ;
  schema:identifier "b-site-readiness-referral" ;
  schema:name "Site readiness and referral pathway delays"@en ;
  schema:description "Getting a patient from 'this treatment might help you' to actually receiving it can take weeks or months, because the scan, the specialist review and the treatment often happen at different places, and not every hospital is equipped to give the treatment at all."@en ;
  schema:url <https://nuclide.cc/bottlenecks/b-site-readiness-referral/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/developing-efficient-patient-referral-pathways-for-radioligand-therapies>, <https://www.targetedonc.com/view/oncologists-encounter-challenges-to-accessing-psma-targeted-therapy-in-prostate-cancer>, <https://jnm.snmjournals.org/content/64/1/47>, <https://www.healthsystemreadiness.com/app/uploads/Health-system-readiness-for-radioligand-therapy-in-the-UK-Service-provision.pdf> ;
  nuclide:tag "access", "referral", "care pathway" ;
  nuclide:related <https://nuclide.cc/bottlenecks/b-hot-lab-capacity/>, <https://nuclide.cc/bottlenecks/b-authorized-user-shortage/>, <https://nuclide.cc/bottlenecks/b-reimbursement-coding/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate-mcrpc/>, <https://nuclide.cc/indications/neuroendocrine/> ;
  nuclide:technologies <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/technologies/sstr-pet/>, <https://nuclide.cc/technologies/radiopharmacy-network/> ;
  nuclide:drugs <https://nuclide.cc/drugs/pluvicto/>, <https://nuclide.cc/drugs/ga68-psma-11/>, <https://nuclide.cc/drugs/ga68-dotatate/> ;
  nuclide:institutions <https://nuclide.cc/institutions/dana-farber/>, <https://nuclide.cc/institutions/snmmi/> .